Advertisement
ImExHS Limited

ImExHS Limited Fundamental Analysis

IME.AXASX
HealthcareMedical - Healthcare Information Services
$0.35
$0.02(7.69%)
Australian Market opens in 15h 24m
Advertisement

ImExHS Limited Fundamental Analysis

ImExHS Limited (IME.AX) shows weak financial fundamentals with a PE ratio of -5.87, profit margin of -9.95%, and ROE of -19.01%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position17.44%
PEG Ratio0.19
Current Ratio1.73

Areas of Concern

ROE-19.01%
Operating Margin0.23%
We analyze IME.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 2.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
2.3/100

We analyze IME.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

IME.AX struggles to generate sufficient returns from assets.

ROA > 10%
-12.15%

Valuation Score

Excellent

IME.AX trades at attractive valuation levels.

PE < 25
-5.87
PEG Ratio < 2
0.19

Growth Score

Weak

IME.AX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IME.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.04
Current Ratio > 1
1.73

Profitability Score

Weak

IME.AX struggles to sustain strong margins.

ROE > 15%
-1901.35%
Net Margin ≥ 15%
-9.95%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is IME.AX Expensive or Cheap?

P/E Ratio

IME.AX trades at -5.87 times earnings. This suggests potential undervaluation.

-5.87

PEG Ratio

When adjusting for growth, IME.AX's PEG of 0.19 indicates potential undervaluation.

0.19

Price to Book

The market values ImExHS Limited at 1.19 times its book value. This may indicate undervaluation.

1.19

EV/EBITDA

Enterprise value stands at 27.41 times EBITDA. This signals the market has high growth expectations.

27.41

How Well Does IME.AX Make Money?

Net Profit Margin

For every $100 in sales, ImExHS Limited keeps $-9.95 as profit after all expenses.

-9.95%

Operating Margin

Core operations generate 0.23 in profit for every $100 in revenue, before interest and taxes.

0.23%

ROE

Management delivers $-19.01 in profit for every $100 of shareholder equity.

-19.01%

ROA

ImExHS Limited generates $-12.15 in profit for every $100 in assets, demonstrating efficient asset deployment.

-12.15%

Following the Money - Real Cash Generation

Operating Cash Flow

ImExHS Limited generates limited operating cash flow of $568.10K, signaling weaker underlying cash strength.

$568.10K

Free Cash Flow

ImExHS Limited generates weak or negative free cash flow of $245.64K, restricting financial flexibility.

$245.64K

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

IME.AX converts 1.28% of its market value into free cash.

1.28%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.87

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.19

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.19

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.66

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.73

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.19

vs 25 benchmark

ROA

Return on assets percentage

-0.12

vs 25 benchmark

ROCE

Return on capital employed

0.004

vs 25 benchmark

How IME.AX Stacks Against Its Sector Peers

MetricIME.AX ValueSector AveragePerformance
P/E Ratio-5.8729.58 Better (Cheaper)
ROE-19.01%391.00% Weak
Net Margin-9.95%-11427.00% (disorted) Weak
Debt/Equity0.040.77 Strong (Low Leverage)
Current Ratio1.735.10 Neutral
ROA-12.15%-260.00% (disorted) Weak

IME.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews ImExHS Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ